Indefinite Delivery Contract SPE2DB22D1202

The Indefinite Delivery Contract SPE2DB was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp as a single-award contract vehicle with a potential value of $999,999,999. Task orders described in the IDV award various pharmaceutical products to support DLA medical logistics programs. Orders valued from $106 to $30,494.61 require delivery of prescription drugs, vaccines, and medical supplies to Amerisourcebergen's facility in Conshohocken, PA, with completion by September 29, 2023 at the latest. No set-asides are specified in orders awarded under the IDV, which aims to efficiently procure necessary medical materiel for the Department of Defense through a prime vendor arrangement. As the leading provider of pharmaceutical distribution to the military health system, Amerisourcebergen Drug Corp performs as the prime contractor on orders to stock critical medications and maintain the DLA's global supply chain in support of military readiness worldwide.

The IDV and subsequent task orders facilitate delivery of diverse products, including analgesics, antibiotics, chronic disease medications, and emergency injectables. Orders provide quantities ranging from individual prescriptions to bulk vaccine shipments for stockpile. Performance locations are limited to Amerisourcebergen's Conshohocken headquarters, indicating distribution from a central pharmaceutical depot. Pricing is set firm-fixed across orders awarded under the IDV on an as-needed basis to fulfill the DLA's ongoing resupply requirements. Time-sensitive deliveries may include single-day periods of performance, underscoring the IDV's function to streamline procurement of essential medical supplies for DOD forces and installations.